Cardiovascular–kidney–metabolic (CKM) syndrome highlights the close relationships among cardiovascular, kidney and metabolic health. Evidence from epidemiological and multiomics studies suggests a link between CKM syndrome and cancer, which raises the possibility that integrated screening and prevention strategies that target shared inflammatory, metabolic and immune pathways could improve patient outcomes.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Hatamizadeh, P. Introducing nephrocardiology. Clin. J. Am. Soc. Nephrol. 17, 311–313 (2022).
Ndumele, C. E. et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American ...